Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Artificial intelligence in endoscopy: navigating risk, responsibility and ethical challenges
0
Zitationen
8
Autoren
2025
Jahr
Abstract
Artificial intelligence (AI) technologies, particularly computer-assisted detection (CADe) and computer-assisted diagnosis (CADx), are increasingly being introduced into routine gastrointestinal endoscopy, especially in colonoscopy. CADe systems assist in real-time polyp detection, while CADx offers in-vivo optical characterisation to guide resection and surveillance decisions. Robust evidence supports CADe’s ability to improve adenoma detection rate, a critical quality metric linked to reduced postcolonoscopy colorectal cancer. However, these clinical gains must be weighed against recognised limitations, including false positives and risks of operator over-reliance. While CADx holds theoretical appeal, recent data have questioned its incremental value over optical diagnosis done by experienced endoscopists, highlighting the ongoing challenges in human–AI interaction and system generalisability. This review synthesises the latest evidence and examines the ethical and practical implications of AI integration in endoscopic practice. We focus on two emerging domains of responsibility: forward-looking responsibility—encompassing clinicians’ roles in understanding, applying and communicating AI use—and outcome responsibility, which considers how accountability is shared across clinicians, developers and institutions when adverse events occur. As these technologies continue to evolve, their successful implementation will depend on clear clinical guidance, robust training programmes and thoughtful governance. CADe and CADx not only enhance detection and diagnostic consistency but also require a re-evaluation of endoscopists’ professional responsibilities in a technologically mediated environment. Supporting clinicians in using these systems safely and ethically will be essential for ensuring they contribute meaningfully to patient care.
Ähnliche Arbeiten
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 · 110.210 Zit.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 · 87.241 Zit.
Global cancer statistics
2011 · 54.998 Zit.
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
2014 · 28.928 Zit.
Global cancer statistics, 2012
2015 · 27.300 Zit.